Aurora Krause is a transformative executive with over 15 years of experience in Investor Relations and Corporate Communications, currently serving as the Head of Corporate Affairs (Interim) at DBV Technologies. Previously, Aurora held positions such as Senior Director of Communications and Investor Relations at Alcyone Therapeutics Inc. and Director of External Communications at Alexion Pharmaceuticals, where they led corporate messaging and strategic communications during significant organizational changes. Aurora's career includes pivotal roles at Synta Pharmaceuticals, Cerulean Pharma, and involvement with the National Investor Relations Institute's Boston Chapter. Aurora is pursuing a Master of Science in Public Relations from Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices